- ACCS
- ADXS
- AEE
- AEYE
- AGO
- ALTR
- AMRC
- ANV
- API
- ARPI
- AT
- ATNM
- AU
- BEST
- BP
- BRCM
- BYOC
- CALX
- CBZ
- CCPR
- CEVA
- CHC
- CHTR
- CNP
- CODE
- COWI
- CTRP
- CY
- CYCC
- DARA
- DMND
- DNAX
- DOGO
- DOX
- DPW
- E
- ECAU
- EGI
- EGO
- ESS
- EXAR
- EXFO
- FCS
- FFIV
- FKWL
- FNEC
- FPI
- FULO
- GCMI
- GEEK
- GLW
- GMK
- GOOGL
- GSIT
- GSVC
- GTXO
- HASI
- HEAR
- HIMX
- HITT
- HMG
- HORI
- ICEL
- IDCC
- IGLD
- INGN
- INGR
- INTC
- ISR
- ITI
- ITMN
- ITSI
- IVR
- IX
- JCDAF
- JDSU
- KED
- KERX
- KT
- LABL
- LLNW
- LMAT
- LONG
- LRY
- LUXR
- MDU
- MIICF
- MITT
- MIXT
- MLNX
- MNOV
- MOSY
- MPLX
- MUSS
- MVG
- MYNG
- NMIH
- NMRX
- NPHC
- NTP
- NTS
- NWBD
- NXST
- OPEN
- OPHT
- OTEL
- PAM
- PIP
- PNTR
- POWI
- PRKA
- PWVI
- QCOM
- RARE
- REPH
- RIIC
- RT
- RUTH
- RXDX
- SALM
- SCG
- SENEA
- SEV
- SJI
- SPA
- SSOL
- STEM
- STON
- SUI
- TDS
- TE
- TECD
- TEF
- TGICQ
- THOR
- TIGR
- TKC
- TMOL
- TREP
- TRMR
- TSRI
- TSU
- TXCCQ
- UNS
- UUU
- VPIG
- VRNT
- VSAT
- WIRE
- WSCO
- WWAG
- YBIN
- ZFC
- ZLCS
Healthcare > Biotechnology > Brainstorm Cell Therapeutics I (BCLI):
Monthly insider trade sell & buy 5 month 1 year 2 years 5 years| Oct09 | Feb10 | Mar11 | Apr11 | May11 | Jun11 | Jul11 | Oct11 | Nov11 | Dec11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Buy Volume | 0 | 0 | 0 | 0 | 200000 | 100000 | 0 | 0 | 0 | 0 |
| Sale Volume | 200000 | 250000 | 285498 | 284820 | 71650 | 33023 | 100000 | 200000 | 10000 | 98333 |
* Disclaimer: Inside trades reported to the U.S. Securities and Exchange Commission. We make no guarantee on the accuracy of the data. For personal use only(includes study, research, education).
Short interest :
- Daily short sale volume for Brainstorm Cell Therapeutics I (BCLI)
- Bi-monthly short interest from NASDAQ
- Insider Transactions for Brainstorm Cell Therapeutics I (Brainstorm Cell Therapeutics I) by Yahoo
- NASDAQ insider trades for Brainstorm Cell Therapeutics I (Brainstorm Cell Therapeutics I)
- Major Holders of Brainstorm Cell Therapeutics I listed by Yahoo
- Brainstorm Cell Therapeutics I (BCLI)owership summary,institutional holdings